FMR reports 6.8% stake in Baxter International
FMR LLC filed a Schedule 13G reporting beneficial ownership of 34,811,770.04 shares of Baxter International Inc. common stock, representing 6.8% of the class as of the event dated 12/31/2025.
Rhea-AI Filing Summary
FMR LLC filed a Schedule 13G reporting beneficial ownership of 34,811,770.04 shares of Baxter International Inc. common stock, representing 6.8% of the class as of the event dated 12/31/2025.
FMR LLC has sole voting power over 23,858,435.30 shares and sole dispositive power over 34,811,770.04 shares. Abigail P. Johnson is also reported as a beneficial owner with sole dispositive power over the same 34,811,770.04 shares. The securities are stated to be held in the ordinary course of business and not for the purpose of changing or influencing control of Baxter.
Positive
- None.
Negative
- None.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Baxter International Inc. (BAX) does FMR LLC report?
Who are the reporting persons in this Baxter (BAX) Schedule 13G filing?
Does FMR LLC intend to influence control of Baxter International (BAX)?
What does Item 6 of this Baxter (BAX) Schedule 13G say about other beneficiaries?
When did the ownership event triggering this Baxter (BAX) Schedule 13G occur?
AI-generated analysis. How Rhea-AI works. Not financial advice.